339792
3,4-二丁氧基-3-环丁烯-1,2-二酮
98%
别名:
方酸二正丁酯
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
[CH3(CH2)3O]2C4(=O)2
化学文摘社编号:
分子量:
226.27
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
产品名称
3,4-二丁氧基-3-环丁烯-1,2-二酮, 98%
InChI
1S/C12H18O4/c1-3-5-7-15-11-9(13)10(14)12(11)16-8-6-4-2/h3-8H2,1-2H3
SMILES string
CCCCOC1=C(OCCCC)C(=O)C1=O
InChI key
XBRWELTXMQSEIN-UHFFFAOYSA-N
assay
98%
form
liquid
refractive index
n20/D 1.494 (lit.)
bp
139 °C/0.5 mmHg (lit.)
density
1.047 g/mL at 25 °C (lit.)
functional group
ether
ketone
Quality Level
Application
3,4-二丁氧基-3-环丁烯-1,2-二酮用于合成新型半方酸染料，可用于在水性介质中进行高选择性Hg2+传感。它也用于合成3-丁氧基-4-(1,3,3-三甲基-2,3-二氢-1H-2-吲哚基亚甲基)-3-环丁烯-1,2-二酮的中间体方酸染料。
General description
3,4-二丁氧基-3-环丁烯-1,2-二酮是方酸的二烷基酯。
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
target_organs
Respiratory system
存储类别
10 - Combustible liquids
wgk
WGK 3
flash_point_f
235.4 °F - closed cup
flash_point_c
113 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Cutaneous lymphoid hyperplasia related to squaric acid dibutyl ester.
Eric A Millican et al.
Journal of the American Academy of Dermatology, 65(1), 230-232 (2011-06-18)
Aaron E Scott et al.
Toxicology and applied pharmacology, 183(1), 66-70 (2002-09-10)
The ability of chemical or pharmaceutical agents to induce allergic contact dermatitis (ACD) is of major health and regulatory concern. As such, tests to identify their sensitizing capacity, such as the guinea pig maximization test and the more recently developed
C Ajith et al.
Journal of drugs in dermatology : JDD, 5(3), 262-266 (2006-04-01)
Immunotherapy with sqauric acid dibutyl ester (SADBE) is a well-accepted therapy for alopecia areata. To study efficacy, safety, and factors influencing the outcome in the treatment of alopecia areata. During a 4-year period, 70 patients of alopecia areata, unresponsive to
Rachid Marhaba et al.
Journal of immunology (Baltimore, Md. : 1950), 179(8), 5071-5081 (2007-10-04)
Induction of a chronic eczema is a most efficient therapy for alopecia areata (AA). We had noted a reduction in regulatory T cells during AA induction and wondered whether regulatory T cells may become recruited or expanded during repeated skin
Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
Kazumasa Morita et al.
The Journal of dermatology, 29(10), 661-664 (2002-11-16)
Topical immunotherapy is effective for severe alopecia areata. However, there are patients with alopecia areata refractory to topical immunotherapy alone. We tried SADBE (squaric acid dibutylester) topical immunotherapy combined with topical dry ice cryotherapy, carpronium chloride (a parasympathetic nerve stimulant)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持